PRAX · Company research
Praxis Precision Medicines, Inc. (PRAX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Is Praxis Precision Medicines (PRAX) Priced Too Highly On Book Value? - Yahoo Finance | Is Praxis Precision Medicines (PRAX) Priced Too Highly On Book Value? Yahoo Finance | View source ↗ | Yahoo Finance | Oct 18, 2026 | neutral | 0 | 0.6 |
| These Two Stocks Hit Fresh 52-Week Highs Today – DCTH Clocks Best Day In Nearly 15 Months - Stocktwits | These Two Stocks Hit Fresh 52-Week Highs Today – DCTH Clocks Best Day In Nearly 15 Months Stocktwits | View source ↗ | Stocktwits | Oct 17, 2026 | neutral | 0 | 0.6 |
| Responsive Playbooks and the PRAX Inflection - Stock Traders Daily | Responsive Playbooks and the PRAX Inflection Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 15, 2026 | neutral | 0 | 0.6 |
| Fourteen new employees receive Praxis stock awards covering 3,478 shares. - Stock Titan | Fourteen new employees receive Praxis stock awards covering 3,478 shares. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Praxis Precision Medicines Slides as Investors Weigh Earlier Trial Miss and Upcoming FDA Decisions - Quiver Quantitative | Praxis Precision Medicines Slides as Investors Weigh Earlier Trial Miss and Upcoming FDA Decisions Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 23, 2026 | neutral | 0 | 0.6 |
| Praxis Precision Medicines Slides as Investors Weigh Earlier Trial Miss and Upcoming FDA Decisions - Quiver Quantitative | Praxis Precision Medicines Slides as Investors Weigh Earlier Trial Miss and Upcoming FDA Decisions Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 23, 2026 | neutral | 0 | 0.6 |
| Sixty-six new employees receive stock awards from Praxis. They vest over four years. - Stock Titan | Sixty-six new employees receive stock awards from Praxis. They vest over four years. Stock Titan | View source ↗ | Stock Titan | Sep 3, 2026 | neutral | 0 | 0.6 |
| Praxis Precision Medicines Slides as Investors Appear to Lock In Gains After Recent Rally - Quiver Quantitative | Praxis Precision Medicines Slides as Investors Appear to Lock In Gains After Recent Rally Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 20, 2026 | neutral | 0 | 0.6 |
| Can Praxis Precision Medicines' (PRAX) Extended Cash Runway Offset Mounting Losses In Its CNS Pipeline Push? - Simply Wall Street | Can Praxis Precision Medicines' (PRAX) Extended Cash Runway Offset Mounting Losses In Its CNS Pipeline Push? Simply Wall Street | View source ↗ | Simply Wall Street | Aug 10, 2026 | neutral | 0 | 0.6 |
| FDA delays Praxis relutrigine review by three months to Dec. 27 - Stock Titan | FDA delays Praxis relutrigine review by three months to Dec. 27 Stock Titan | View source ↗ | Stock Titan | Jun 29, 2026 | neutral | 0 | 0.6 |
| Praxis Precision Medicines Stock Surges 27%, With A 6-Day Winning Spree - Trefis | Praxis Precision Medicines Stock Surges 27%, With A 6-Day Winning Spree Trefis | View source ↗ | Trefis | Jun 26, 2026 | neutral | 0 | 0.6 |
| PRAX Forecast — Price Target — Prediction for 2027 - TradingView | PRAX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Praxis Precision Medicines (PRAX) Stock After Mixed POWER1 Trial Results How Does The Valuation Stack Up - Yahoo Finance | Praxis Precision Medicines (PRAX) Stock After Mixed POWER1 Trial Results How Does The Valuation Stack Up Yahoo Finance | View source ↗ | Yahoo Finance | Jun 14, 2026 | neutral | 0 | 0.6 |
| Praxis Precision Medicines (PRAX) Shares Phase 2/3 POWER1 Study Findings - Yahoo Finance | Praxis Precision Medicines (PRAX) Shares Phase 2/3 POWER1 Study Findings Yahoo Finance | View source ↗ | Yahoo Finance | Jun 5, 2026 | neutral | 0 | 0.6 |
| PRAX Stock Drops 12% After Hours On Trial Setback — Retail Eyes FDA Approval Of Other Pipeline Candidates - Stocktwits | PRAX Stock Drops 12% After Hours On Trial Setback — Retail Eyes FDA Approval Of Other Pipeline Candidates Stocktwits | View source ↗ | Stocktwits | Jun 1, 2026 | neutral | 0 | 0.6 |
| Praxis Precision Medicines (PRAX): Best Mid Cap Stocks to Buy with Highest Upside Potential - Yahoo Finance | Praxis Precision Medicines (PRAX): Best Mid Cap Stocks to Buy with Highest Upside Potential Yahoo Finance | View source ↗ | Yahoo Finance | May 28, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.